Nurix Therapeutics
Latest round
- Series D
Last raised
- Mar 2020
Total raised
- $125M
Investors
- 8
About Nurix Therapeutics
Based in the US, Nurix Therapeutics, Inc.Founded in 2012 in San Francisco, US, Nurix Therapeutics, Inc. specializes in leveraging protein degradation technology for drug development. Michael Rape is the founder, and Arthur Sands serves as CEO.Nurix Therapeutics specializes in the development of innovative medicines that leverage targeted protein degradation technology to combat various diseases, particularly cancers and autoimmune disorders. Their primary offerings include degraders and Degrader-Antibody Conjugates (DACs), which are engineered to eliminate disease-causing proteins by utilizing the natural protein degradation processes of cells. These products aim to deliver enhanced precision and improved safety in treatment outcomes, thus addressing unmet medical needs in oncology and immunology.53 mn.Nurix Therapeutics is focused on expanding its product portfolio and market presence. The company aims to introduce additional targeted therapies to the market by 2025 and plans to expand its operations into Europe and Asia by identifying partners in those regions. Additionally, with a strong pipeline including products like NX-5948, Nurix is positioned to enhance its offering in treating serious health conditions.
Who invested in Nurix Therapeutics
8 investors across 3 rounds
See all investors in Nurix Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nurix Therapeutics
Who invested in Nurix Therapeutics?
Nurix Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nurix Therapeutics raised?
Nurix Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nurix Therapeutics last raise money?
Nurix Therapeutics's most recent round on record is a Series D, in Mar 2020.
What does Nurix Therapeutics do?
Based in the US, Nurix Therapeutics, Inc.
Where is Nurix Therapeutics headquartered?
Nurix Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Nurix Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nurix Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Nurix Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.